Year: 2017
Type: review
Abstract: Uncoupling protein 2 (UCP2) is an inner mitochondrial membrane protein that belongs to the uncoupling protein family and plays an important role in lowering mitochondrial membrane potential and dissipating metabolic energy with prevention of oxidative stress accumulation. In the present article, we will review the evidence that UCP2, as a consequence of its roles within the mitochondria, represents a critical player in the predisposition to vascular disease development in both animal models and in humans, particularly in relation to obesity, diabetes, and hypertension. The deletion of the UCP2 gene contributes to atherosclerosis lesion development in the knockout mice, also showing significantly shorter lifespan. The UCP2 gene downregulation is a key determinant of higher predisposition to renal and cerebrovascular damage in an animal model of spontaneous hypertension and stroke. In contrast, UCP2 overexpression improves both hyperglycemia- and high-salt diet-induced endothelial dysfunction and ameliorates hypertensive target organ damage in SHRSP. Moreover, drugs (fenofibrate and sitagliptin) and several vegetable compounds (extracts from Brassicaceae, berberine, curcumin, and capsaicin) are able to induce UCP2 expression level and to exert beneficial effects on the occurrence of vascular damage. As a consequence, UCP2 becomes an interesting therapeutic target for the treatment of common human vascular diseases.
DOI: 10.1155/2017/7348372
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: UCP2, vascular disease, mitochondrial membrane potential, oxidative stress, atherosclerosis, hypertension, obesity, diabetes mellitus, endothelial dysfunction, hypertensive target organ damage, stroke, kidney injury, fenofibrate, sitagliptin, berberine, curcumin, capsaicin, therapeutic target
Open Access status: hybrid
Estimated APC paid: $2,680
Funder: Ministero della Salute
OpenAlex ID: W2763106122
